Whole body FDG PET study for the initial staging of cancer, for a patient who is considered suitable for active therapy, if:(a) the cancer is a typically FDG-avid cancer; and(b) there is at least 10% likelihood that a PET study result will inform a significant change in management for the patientApplicable once per cancer diagnosis (R)